FARNUM RHONDA (SVP, Comm & Medical Affairs) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2025ACC: 0001415889-25-022794
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-9.10K
Net shares
Net seller
$121.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.10K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−9.10K
Price / share
$13.39
Trade value
$121.80K
% of position
2.8%
8/20/2025
326.92K→317.82K
Total
Net shares
−9.10K
Net value
-$121.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2025 | F · Tax Withholding | −9.10K | $13.39 | $121.80K | 2.8% | 326.92K | 317.82K |
| Total | −9.10K | -$121.80K | ||||||
Derivative Transactions0
No derivative transactions reported